Latest news
First-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models - Pharmacy TimesPharmacy Times · Mon, 10 Aug 2026 19:16:31 GMTNurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 16:44:14 GMTArvinas Q2 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 14:04:34 GMT